Raymond Vennare | executive |
Joshua Blacher | executive |
Ladies and gentlemen, good morning, and thank you for standing by. Welcome to the Predictive Oncology Q1 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. And I would now like to hand the conference over to your speaker, Mr. Glenn Garmont, Investor Relations.